MiniMed Insulin Pump

Find a Lawyer in Your State

Need Help?

Contact Us Today

Call Today: (800) 653-9958

I agree that submitting this form and the information contained within does not establish an attorney client relationship.

ATTORNEY ADVERTISING -
Flood Law Group, LLP
1101 Pennsylvania Avenue
Suite 600
Washington, DC 20004
(888) 334-2084

Privacy protected. All information held in the strictest confidence.

Medtronic Paradigm Insulin Pump 715

First introduced in 2004, the Medtronic Paradigm Insulin Pump is the newest version of the MiniMed Insulin Pump 722. Building on over 20 years of innovations, the Paradigm Insulin Pump 715 contains the newest technologies to reduce human error and simplify:

blood glucose testing
calculation of insulin dosage
administration of insulin

The Medtronic Paradigm Pump 715 is currently available via prescription, and current Medtronic MiniMed patients can get affordable upgrades to this device if their current pump is still under warranty.

New Features of the MiniMed Pump 715

Innovations included in the Paradigm Pump 715 include:

The ability to manage pump data on the pump's screen : Diabetes patients can now access various information regarding their blood sugar and insulin intake, including their insulin delivery patterns and carbohydrate data.
A Web-based therapy management system : Known as CareLink for Diabetics, this online program allows diabetes patients to compile their blood sugar history from various devices into a single, simplified report. These reports promote more efficient self-management of diabetes and make it easier to talk about the specifics of the condition with physicians and nurses.

Existing features that have been enhanced in the latest version of Medtronic's insulin pump therapy system include (but aren't limited to) the:

Bolus Wizard Dosing Calculator
Target Blood Sugar Meter
Home screen icons
Data Management System
Save & Restore Settings
Therapy Management Software Tools

2009 Recall of Insulin Pump Therapy Systems

In July 2009, Medtronic voluntarily recalled approximately 3 million insulin pump systems because:

About 60,000 devices in Lot 8 were suspected to be defective
More than 200 diabetes patients were severely injured and hospitalized after using defective infusion sets and pump systems (An infusion set, known officially as the Quick-set Infusion Set, is a disposable device that inserts a small tube beneath the skin to diabetics can constantly receive insulin)

Hyperglycemia, dangerously high blood sugar levels, was the primary injury sustained and it typically developed as a result of the cannula (the small tube placed in the skin) becoming bent or disconnected (either from the skin or the pump).

Hyperglycemia is an extremely serious condition and is known to cause blindness, heart disease and fatality if left untreated.

Diabetes patients who develop hyperglycemia or other serious injuries after using defective Insulin Pump Therapy Systems may be entitled to seek and recover compensation for damages including medical bills, lost wages and pain and suffering. To find out if you qualify to seek monetary compensation, please contact our MiniMed Insulin Pump Lawyers.

Our injury and death lawyers are investigating all MiniMed cases. Our evaluations are not limited to persons injured by the recalled "Lot 8" infusion sets. To discuss the details of your unique circumstances, please contact our law offices today.

Online Lawyer Source

Lawyers & Legal News Near You

Need Legal Help?

Start Here for a Free Case Review!